Newsroom

Watch this short video discussing the CHiRP Study, which evaluated circulating tumor DNA (ctDNA) and late recurrence in high-risk hormone receptor positive, HER2-negative breast cancer.

Hematologic malignancies pose many challenges – from diagnostic subtyping, to risk stratification and even in therapy selection.

Ep. 1 Ch. 1 - Addressing issues in lung cancer biomarker testing.

Ep. 1 Ch. 2 - The complexity of EGFR mutations.

Ep. 1 Ch. 3 - What we need to know about EGFR exon 20 insertion mutations.

Ep. 1 Ch. 4 - Improving detection of EGFR insertion mutation using NGS

Ep. 1 Ch. 5 - Why oncology is a team sport – and how we can be better players